TY - JOUR
T1 - Distinct patterns of inactivation of p15(INK4B) and p16(INK4A) characterize the major types of hematological malignancies
AU - Herman, James G.
AU - Civin, Curt I.
AU - Issa, Jean Pierre J.
AU - Collector, Michael I.
AU - Sharkis, Saul J.
AU - Baylin, Stephen B.
PY - 1997
Y1 - 1997
N2 - Inactivation of the cyclin-dependent kinase inhibitors p16(INK4A) and p15(INK4B) are frequent alterations in neoplasia, often resulting from homozygous deletion or promoter region hypermethylation. We have analyzed both modes of inactivation of p15(INK4B) and p16(INK4A) in the major types of adult and pediatric hematological malignancies. Hypermethylation of p15(INK4B), without alteration of p16(INK4A), was an almost universal finding in adult acute myelogenous leukemia, and occurred very frequently in adult acute lymphocytic leukemia and pediatric acute myelogenous leukemia and acute lymphocytic leukemia. In contrast, neither p15(INK4B) nor p16(INK4A) were inactivated in any stage of chronic myelogenous leukemia. Hypermethylation of p16(INK4A), often without alterations of p15(INK4B), was found in non- Hodgkin's lymphoma and was much more frequent in cases with high-grade than low-grade histology. Enriched normal bone marrow stem cells had no detectable promoter region methylation of these genes, as analyzed by a newly developed PCR method. Remarkably distinct patterns of inactivation of p15(INK4B) and p16(INK4A) characterize different types of hematological malignancy, and alterations in these tumor suppressor genes are one of the most common alterations in hematological malignancies.
AB - Inactivation of the cyclin-dependent kinase inhibitors p16(INK4A) and p15(INK4B) are frequent alterations in neoplasia, often resulting from homozygous deletion or promoter region hypermethylation. We have analyzed both modes of inactivation of p15(INK4B) and p16(INK4A) in the major types of adult and pediatric hematological malignancies. Hypermethylation of p15(INK4B), without alteration of p16(INK4A), was an almost universal finding in adult acute myelogenous leukemia, and occurred very frequently in adult acute lymphocytic leukemia and pediatric acute myelogenous leukemia and acute lymphocytic leukemia. In contrast, neither p15(INK4B) nor p16(INK4A) were inactivated in any stage of chronic myelogenous leukemia. Hypermethylation of p16(INK4A), often without alterations of p15(INK4B), was found in non- Hodgkin's lymphoma and was much more frequent in cases with high-grade than low-grade histology. Enriched normal bone marrow stem cells had no detectable promoter region methylation of these genes, as analyzed by a newly developed PCR method. Remarkably distinct patterns of inactivation of p15(INK4B) and p16(INK4A) characterize different types of hematological malignancy, and alterations in these tumor suppressor genes are one of the most common alterations in hematological malignancies.
UR - http://www.scopus.com/inward/record.url?scp=0031025368&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031025368&partnerID=8YFLogxK
M3 - Article
C2 - 9041182
AN - SCOPUS:0031025368
VL - 57
SP - 837
EP - 841
JO - Cancer Research
JF - Cancer Research
SN - 0008-5472
IS - 5
ER -